5/22/2015 - 11:41 AM EST - Merus Labs International Inc : announced that one of its wholly owned subsidiaries has signed a definitive agreement to acquire the rights to manufacture, market, and sell two established specialty pharmaceutical products in certain European and other markets. Merus Labs International Inc
shares T.MSL are trading down $0.05 at $2.97.
